TYMI

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 1/05/2017
Contact Info
  • 48 Wall Street
  • Suite 1100
  • New York, NY 10005

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-K
CIK 0001537917
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2011
Employees Not Available
Company Officers/Contacts
Steven Hoffman CEO
Michael Demurjian COO
Timothy Tyson Advisor
Company Directors
Michael Demurjian
Steven Hoffman
Gerald Sokol
Tommy Thompson
Service Providers
Accounting/Auditing Firm
Grant Thornton
666 Third Avenue
New York, NY, 10017
United States
 
WithumSmith+Brown
One Spring Street
New Brunswick, NJ, 08901
United States
 
Securities Counsel

Not Available
Investor Relations Firm
In-Site Communications, Inc.
515 Madison Avenue
Suite 14B
New York, NY, 10022
United States
 
TYMI Security Details
Share Structure
Market Value1 $268,023,201 a/o Jun 23, 2017
Authorized Shares 300,000,000 a/o Sep 30, 2016
Outstanding Shares 89,341,067 a/o May 26, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 10,175,400 a/o Apr 18, 2016
Par Value Not Available
Shareholders
Shareholders of Record 198 a/o Aug 01, 2016
Short Selling Data
Short Interest 5,468 (0%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security